Cargando…

Age‐specific severity of severe acute respiratory syndrome coronavirus 2 in February 2020 to June 2021 in the Netherlands

BACKGROUND: The severity of Severe Acute Respiratory Syndrome Coronavirus 2 infection varies with age and time. Here, we quantify how age‐specific risks of hospitalization, intensive care unit (ICU) admission, and death upon infection changed from February 2020 to June 2021 in the Netherlands. METHO...

Descripción completa

Detalles Bibliográficos
Autores principales: de Boer, Pieter T., van de Kassteele, Jan, Vos, Eric R. A., van Asten, Liselotte, Dongelmans, Dave A., van Gageldonk‐Lafeber, Arianne B., den Hartog, Gerco, Hofhuis, Agnetha, van der Klis, Fiona, de Lange, Dylan W., Stoeldraijer, Lenny, de Melker, Hester E., Geubbels, Eveline, van den Hof, Susan, Wallinga, Jacco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10444602/
https://www.ncbi.nlm.nih.gov/pubmed/37621921
http://dx.doi.org/10.1111/irv.13174
_version_ 1785093984300826624
author de Boer, Pieter T.
van de Kassteele, Jan
Vos, Eric R. A.
van Asten, Liselotte
Dongelmans, Dave A.
van Gageldonk‐Lafeber, Arianne B.
den Hartog, Gerco
Hofhuis, Agnetha
van der Klis, Fiona
de Lange, Dylan W.
Stoeldraijer, Lenny
de Melker, Hester E.
Geubbels, Eveline
van den Hof, Susan
Wallinga, Jacco
author_facet de Boer, Pieter T.
van de Kassteele, Jan
Vos, Eric R. A.
van Asten, Liselotte
Dongelmans, Dave A.
van Gageldonk‐Lafeber, Arianne B.
den Hartog, Gerco
Hofhuis, Agnetha
van der Klis, Fiona
de Lange, Dylan W.
Stoeldraijer, Lenny
de Melker, Hester E.
Geubbels, Eveline
van den Hof, Susan
Wallinga, Jacco
author_sort de Boer, Pieter T.
collection PubMed
description BACKGROUND: The severity of Severe Acute Respiratory Syndrome Coronavirus 2 infection varies with age and time. Here, we quantify how age‐specific risks of hospitalization, intensive care unit (ICU) admission, and death upon infection changed from February 2020 to June 2021 in the Netherlands. METHODS: A series of large representative serology surveys allowed us to estimate age‐specific numbers of infections in three epidemic periods (late‐February 2020 to mid‐June 2020, mid‐June 2020 to mid‐February 2021, and mid‐February 2021 to late‐June 2021). We accounted for reinfections and breakthrough infections. Severity measures were obtained by combining infection numbers with age‐specific numbers of hospitalization, ICU admission, and excess all‐cause deaths. RESULTS: There was an accelerating, almost exponential, increase in severity with age in each period. The rate of increase with age was the highest for death and the lowest for hospitalization. In late‐February 2020 to mid‐June 2020, the overall risk of hospitalization upon infection was 1.5% (95% confidence interval [CI] 1.3–1.8%), the risk of ICU admission was 0.36% (95% CI: 0.31–0.42%), and the risk of death was 1.2% (95% CI: 1.0–1.4%). The risk of hospitalization was significantly increased in mid‐June 2020 to mid‐February 2021, while the risk of ICU admission remained stable over time. The risk of death decreased over time, with a significant drop among ≥70‐years‐olds in mid‐February 2021 to late‐June 2021; COVID‐19 vaccination started early January 2021. CONCLUSION: Whereas the increase in severity of Severe Acute Respiratory Syndrome Coronavirus 2 with age remained stable, the risk of death upon infection decreased over time. A significant drop in risk of death among elderly coincided with the introduction of COVID‐19 vaccination.
format Online
Article
Text
id pubmed-10444602
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-104446022023-08-24 Age‐specific severity of severe acute respiratory syndrome coronavirus 2 in February 2020 to June 2021 in the Netherlands de Boer, Pieter T. van de Kassteele, Jan Vos, Eric R. A. van Asten, Liselotte Dongelmans, Dave A. van Gageldonk‐Lafeber, Arianne B. den Hartog, Gerco Hofhuis, Agnetha van der Klis, Fiona de Lange, Dylan W. Stoeldraijer, Lenny de Melker, Hester E. Geubbels, Eveline van den Hof, Susan Wallinga, Jacco Influenza Other Respir Viruses Original Articles BACKGROUND: The severity of Severe Acute Respiratory Syndrome Coronavirus 2 infection varies with age and time. Here, we quantify how age‐specific risks of hospitalization, intensive care unit (ICU) admission, and death upon infection changed from February 2020 to June 2021 in the Netherlands. METHODS: A series of large representative serology surveys allowed us to estimate age‐specific numbers of infections in three epidemic periods (late‐February 2020 to mid‐June 2020, mid‐June 2020 to mid‐February 2021, and mid‐February 2021 to late‐June 2021). We accounted for reinfections and breakthrough infections. Severity measures were obtained by combining infection numbers with age‐specific numbers of hospitalization, ICU admission, and excess all‐cause deaths. RESULTS: There was an accelerating, almost exponential, increase in severity with age in each period. The rate of increase with age was the highest for death and the lowest for hospitalization. In late‐February 2020 to mid‐June 2020, the overall risk of hospitalization upon infection was 1.5% (95% confidence interval [CI] 1.3–1.8%), the risk of ICU admission was 0.36% (95% CI: 0.31–0.42%), and the risk of death was 1.2% (95% CI: 1.0–1.4%). The risk of hospitalization was significantly increased in mid‐June 2020 to mid‐February 2021, while the risk of ICU admission remained stable over time. The risk of death decreased over time, with a significant drop among ≥70‐years‐olds in mid‐February 2021 to late‐June 2021; COVID‐19 vaccination started early January 2021. CONCLUSION: Whereas the increase in severity of Severe Acute Respiratory Syndrome Coronavirus 2 with age remained stable, the risk of death upon infection decreased over time. A significant drop in risk of death among elderly coincided with the introduction of COVID‐19 vaccination. John Wiley and Sons Inc. 2023-08-22 /pmc/articles/PMC10444602/ /pubmed/37621921 http://dx.doi.org/10.1111/irv.13174 Text en © 2023 The Authors. Influenza and Other Respiratory Viruses published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
de Boer, Pieter T.
van de Kassteele, Jan
Vos, Eric R. A.
van Asten, Liselotte
Dongelmans, Dave A.
van Gageldonk‐Lafeber, Arianne B.
den Hartog, Gerco
Hofhuis, Agnetha
van der Klis, Fiona
de Lange, Dylan W.
Stoeldraijer, Lenny
de Melker, Hester E.
Geubbels, Eveline
van den Hof, Susan
Wallinga, Jacco
Age‐specific severity of severe acute respiratory syndrome coronavirus 2 in February 2020 to June 2021 in the Netherlands
title Age‐specific severity of severe acute respiratory syndrome coronavirus 2 in February 2020 to June 2021 in the Netherlands
title_full Age‐specific severity of severe acute respiratory syndrome coronavirus 2 in February 2020 to June 2021 in the Netherlands
title_fullStr Age‐specific severity of severe acute respiratory syndrome coronavirus 2 in February 2020 to June 2021 in the Netherlands
title_full_unstemmed Age‐specific severity of severe acute respiratory syndrome coronavirus 2 in February 2020 to June 2021 in the Netherlands
title_short Age‐specific severity of severe acute respiratory syndrome coronavirus 2 in February 2020 to June 2021 in the Netherlands
title_sort age‐specific severity of severe acute respiratory syndrome coronavirus 2 in february 2020 to june 2021 in the netherlands
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10444602/
https://www.ncbi.nlm.nih.gov/pubmed/37621921
http://dx.doi.org/10.1111/irv.13174
work_keys_str_mv AT deboerpietert agespecificseverityofsevereacuterespiratorysyndromecoronavirus2infebruary2020tojune2021inthenetherlands
AT vandekassteelejan agespecificseverityofsevereacuterespiratorysyndromecoronavirus2infebruary2020tojune2021inthenetherlands
AT vosericra agespecificseverityofsevereacuterespiratorysyndromecoronavirus2infebruary2020tojune2021inthenetherlands
AT vanastenliselotte agespecificseverityofsevereacuterespiratorysyndromecoronavirus2infebruary2020tojune2021inthenetherlands
AT dongelmansdavea agespecificseverityofsevereacuterespiratorysyndromecoronavirus2infebruary2020tojune2021inthenetherlands
AT vangageldonklafeberarianneb agespecificseverityofsevereacuterespiratorysyndromecoronavirus2infebruary2020tojune2021inthenetherlands
AT denhartoggerco agespecificseverityofsevereacuterespiratorysyndromecoronavirus2infebruary2020tojune2021inthenetherlands
AT hofhuisagnetha agespecificseverityofsevereacuterespiratorysyndromecoronavirus2infebruary2020tojune2021inthenetherlands
AT vanderklisfiona agespecificseverityofsevereacuterespiratorysyndromecoronavirus2infebruary2020tojune2021inthenetherlands
AT delangedylanw agespecificseverityofsevereacuterespiratorysyndromecoronavirus2infebruary2020tojune2021inthenetherlands
AT stoeldraijerlenny agespecificseverityofsevereacuterespiratorysyndromecoronavirus2infebruary2020tojune2021inthenetherlands
AT agespecificseverityofsevereacuterespiratorysyndromecoronavirus2infebruary2020tojune2021inthenetherlands
AT demelkerhestere agespecificseverityofsevereacuterespiratorysyndromecoronavirus2infebruary2020tojune2021inthenetherlands
AT geubbelseveline agespecificseverityofsevereacuterespiratorysyndromecoronavirus2infebruary2020tojune2021inthenetherlands
AT vandenhofsusan agespecificseverityofsevereacuterespiratorysyndromecoronavirus2infebruary2020tojune2021inthenetherlands
AT wallingajacco agespecificseverityofsevereacuterespiratorysyndromecoronavirus2infebruary2020tojune2021inthenetherlands